FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/12/2022
Back to search
Official data from USPTO
REYON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
06/12/2022
Trademark type
Combined
Nice classes
5, 35
Filing date
09/09/2020
Registration date
11/30/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/30/2021
Last transaction
11/30/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
KR
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
REYON PHARMACEUTICAL CO.,LTD.
Representatives
COREY A. DONALDSON FERGUSON CASE ORR PATERSON LLP
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical agents affecting metabolism; vitamin and mineral preparations for medical use; crude medicinesmedicines for the treatment and prevention of atopic skin diseaseobesitydigestive disordersimmune system related diseases and disorders; anti-inflammatory and antipyretic preparations; cardiovascular pharmaceutical preparations; dietetic food supplements; food for babies; preparations of microorganisms for medical or veterinary use; medical and surgical plasters; pharmaceutical and veterinary preparations for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricimmune system related diseases and disorders; pharmaceutical and veterinary preparations for treating allergic rhinitis and asthma; pharmaceutical and veterinary preparations for ocular and intraocular surgery; pharmaceutical and veterinary preparations acting on the central nervous system; pharmaceutical and veterinary preparations for the prevention of osteoporosis; pharmaceutical and veterinary preparations for use in urology; pharmaceutical and veterinary preparationsdrug delivery systems comprising polymer-based oral tablets for the continuous release of therapeutic agents; pharmaceutical and veterinary preparations for use in the anesthesia; pharmaceutical and veterinary preparations for diagnostic purposes; pharmaceutical and veterinary preparations for the peripheral nervous system; pharmaceutical and veterinary preparations for digestive organs; pharmaceutical and veterinary preparations for anti-fungal treatment; nutraceutical preparations for therapeutic or medical purposes; antibiotics; anti-cancer preparations; pharmaceutical preparations for respiratory organs; all aforementioned goods sold only to hospitals or other healthcare institutions and to pharmaceutical companies
Class 35
Wholesale store services featuring dietary supplements for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies; wholesale store services featuring drugs for medical purposes for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies; wholesale store services featuring medicines for human purposes for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies; business intermediary services relating to mail order by telecommunicationsmail order pharmacy services for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies; wholesale store services featuring analgesics for goods and services sold only to hospitals or other healthcare institutions and to pharmaceutical companies
Publications
History of USPTO decisions and trademark events.
21 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/21/2022
FIMP
FINAL DISPOSITION PROCESSED
05/20/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/30/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/14/2021
PUBO
PUBLISHED FOR OPPOSITION
09/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/26/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/03/2021
RFNT
REFUSAL PROCESSED BY IB
02/21/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/04/2021
RFRR
REFUSAL PROCESSED BY MPU
02/04/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/22/2021
CNRT
NON-FINAL ACTION WRITTEN
01/21/2021
DOCK
ASSIGNED TO EXAMINER
01/19/2021
MAFR
APPLICATION FILING RECEIPT MAILED
12/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/30/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/26/2020
Continuous trademark protection
Get notified about every new filing that threatens REYON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.